CureGene Completes First‑Participant Dose in Phase I Trial of CG‑0416, Advancing Clinical Development of Novel Oral Liver-Targeting THR-β Agonist
Press Release

CureGene Completes First‑Participant Dose in Phase I Trial of CG‑0416, Advancing Clinical Development of Novel Oral Liver-Targeting THR-β Agonist

SHANGHAI, Aug. 21, 2026 /PRNewswire/ — CureGene recently announced that the first subject has been dosed in its Phase I clinical trial of CG-0416, a novel oral liver-targeting THR-β agonist developed in-house, in Australia. Subject enrollment is progressing smoothly. CG-0416 is designed based on CureGene’s proprietary prodrug platform, incorporating precise design and structural optimization to […]

Read More
AXIS-Y Expands GCC Presence with Landmark Kuwait and Bahrain Launch
Press Release

AXIS-Y Expands GCC Presence with Landmark Kuwait and Bahrain Launch

The vegan, climate-inspired K-beauty brand strengthens its Middle East footprint through Korea Town by Boutiqaat, debuting dedicated retail experiences and a three-day Kuwait launch activation. SEOUL, South Korea and KUWAIT CITY, Kuwait , Aug. 21, 2026 /PRNewswire/ — AXIS-Y, the vegan, climate-inspired K-beauty skincare brand redefining skin health through its "Climate of You" philosophy, announced […]

Read More
LightInTheBox to Report Second Quarter 2026 Financial Results on Wednesday, August 26, 2026
Press Release

LightInTheBox to Report Second Quarter 2026 Financial Results on Wednesday, August 26, 2026

SINGAPORE, Aug. 21, 2026 /PRNewswire/ — LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2026 before the open of U.S. markets on Wednesday, August 26, 2026. LightInTheBox’s management will hold an earnings […]

Read More
Connecting East Asia, Embracing the World: Contemporary Echoes of Confucian Dialogue
Press Release

Connecting East Asia, Embracing the World: Contemporary Echoes of Confucian Dialogue

GUIYANG, China, Aug. 21, 2026 /PRNewswire/ — A News Report by Huanqiu.com On August 7, the keynote speech and outcomes release conference of the 2026 "Chinese Learning of the Heart-Mind and the World"-An East Asian Dialogue on Confucianism was held at the Confucius Academy in Guiyang, which systematically presented academic outcomes from the weeklong series of […]

Read More
The "Go Guangdong, Go Global" Salon Indonesia Session Held in Guangzhou
Press Release

The "Go Guangdong, Go Global" Salon Indonesia Session Held in Guangzhou

GUANGZHOU, China, Aug. 21, 2026 /PRNewswire/ — A news report from Yangcheng Evening News:  On August 18, the 2026 "Go Guangdong, Go Global" Salon Indonesia session was held in Guangzhou. More than 100 representatives from government, business, academia, finance, legal circles, and business associations, from both China and Indonesia attended the event. Andalusia Tribuana Tungga Dewi, Acting […]

Read More
COMEX Celebrates 35th Anniversary, Returns to Suntec Convention Centre from 3-6 September 2026
Press Release

COMEX Celebrates 35th Anniversary, Returns to Suntec Convention Centre from 3-6 September 2026

Milestone "Tech Comes to Life" edition brings together 400+ leading tech and lifestyle brands for COMEX’s biggest 35th Anniversary Deal Fest yet. SINGAPORE, Aug. 21, 2026 /PRNewswire/ — COMEX, Singapore’s longest-running consumer technology exhibition, returns to Suntec Convention Centre from 3 to 6 September 2026, marking 35 years as the nation’s premier destination for tech deals, […]

Read More
Robo.ai Inc. Announces Appointment of Wang Hao, Senior Executive Officer of UAE Independent Digital Asset Custodian Changer.ae, as Independent Director
Press Release

Robo.ai Inc. Announces Appointment of Wang Hao, Senior Executive Officer of UAE Independent Digital Asset Custodian Changer.ae, as Independent Director

ABU DHABI, UAE, Aug. 21, 2026 /PRNewswire/ — Robo.ai Inc. (Nasdaq: AIIO) (the "Company" or "Robo.ai"), a UAE-based Nasdaq-listed company, today announced the appointment of Mr. Hao Wang as an independent director of the Company’s board of directors (the "Board"), effective immediately. Mr. Wang also will serve as a member of the Board’s Audit Committee, […]

Read More
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy
Press Release

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy

NANJING, China, Aug. 21, 2026 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for Opamtistomig (LBL-024), the Company’s proprietary PD-L1/4-1BB bispecific antibody, as a monotherapy for the […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.